| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 06/29/2006 | US20060142363 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
| 06/29/2006 | US20060142325 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 06/29/2006 | US20060142318 eating disorders of disturbed fundus such as dyspepsia, early satiety, bloating, anorexia; fundic relaxation; 1-[1-[(2,3-dihydro[1,4]dioxino[2,3-b]pyridin-3-yl)methyl]-4-piperidinyl]-2-imidazolidinone; improved pharmacokinetics, less vasoconstriction, side effect reduction, sustain release |
| 06/29/2006 | CA2592119A1 Pyrrolo[2,3-b]pyridin-4-yl-amines and pyrrolo[2,3-b]pyrimidin-4-yl-amines as janus kinase inhibitors |
| 06/29/2006 | CA2590756A1 Stereoselective process and crystalline forms of a camptothecin |
| 06/29/2006 | CA2589331A1 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/28/2006 | EP1674101A1 Cinnamates of Benzo[b]pyrano[3,2-h]acridin-7-one, process for preparation thereof and their pharmaceutical composition |
| 06/28/2006 | EP1673373A2 Indole derivatives |
| 06/28/2006 | EP1673088A1 1,1,1- trifluoro-4-phenyl-4-methyl-2-(1h-pyrrolo¬2,3-c|pyridin-2-ylmethyl)pentan-2-ol derivatives and related compounds as glucocorticoid ligands for the treatment of inflammatory diseases and diabetes |
| 06/28/2006 | EP1492539B1 Statin therapy for enhancing cognitive maintenance |
| 06/28/2006 | CN1793145A 7-bit substituted comptothecine kind compound and pharmaceutical use thereof |
| 06/28/2006 | CN1261434C Method for separating high-purity galanthamine from short-tube lycoris crude extract |
| 06/27/2006 | USRE39151 Process for the preparation and purification of thiol-containing maytansinoids |
| 06/27/2006 | US7067670 Sulfamato hydroxamic acid metalloprotease inhibitor |
| 06/27/2006 | US7067667 Aminoalkyl-3, 4-dihydroquinoline derivatives as no-synthase inhibitors |
| 06/27/2006 | US7067666 7-substituted camptothecin and camptothecin analogs and methods for producing the same |
| 06/27/2006 | US7067665 phenylethoxy-phenyl- or -pyridyl- (acet) amides, N-substituted with pyrimidine ring-containing (tetrahydro)pyridines or phenyl groups; e.g., 3-[2-(2,4-Dichloro-phenyl)-ethoxy]-4-methoxy-N-[4-(pyrimidin-2-ylsulfamoyl)-phenyl]-benzamide; treating cardiovascular disorders such as thromboses and restenoses |
| 06/27/2006 | US7067525 Compounds useful as modulators of Melanocortin Receptors and pharmaceutical compositions comprising same |
| 06/27/2006 | US7067517 Use of compounds for decreasing activity of hormone-sensitive lipase |
| 06/27/2006 | US7067515 Quinuclidines-substituted-multi-cyclic-heteroaryls for the treatment of disease |
| 06/27/2006 | US7067286 Cystobacterineae host cells containing heterologous PKS genes for the synthesis of polykedtides |
| 06/27/2006 | CA2326710C New dihydrofuro-¬3,4-b|quinolein-1-ones derivatives, the procedure for preparing them and the pharmaceutical compositions that contain them |
| 06/22/2006 | WO2006065828A2 Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 06/22/2006 | WO2006065711A2 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 06/22/2006 | WO2006065479A2 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | WO2006065448A2 Topoisomerase inhibitors and prodrugs |
| 06/22/2006 | WO2006064355A2 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 06/22/2006 | WO2006064105A1 Use of centrifugal partition chromatography for purifying galanthamine |
| 06/22/2006 | WO2006063666A1 Process for the preparation of galanthamine hydrobromide |
| 06/22/2006 | WO2006036883A3 Imidazo{4,5-b}pyrazinone inhibitors of protein kinases |
| 06/22/2006 | WO2005121327A3 Biosynthetic gene cluster for the production of a complex polyketide |
| 06/22/2006 | WO2005087731A8 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/22/2006 | US20060135550 Rapamycin derivatives and the uses thereof in the treatment of neurological disorders |
| 06/22/2006 | US20060135549 Rapamycin analogues and the uses thereof in the treatment of neurological, proliferative,and inflammatory disorders |
| 06/22/2006 | US20060135548 Such as pimecrolimus and tacrolimus |
| 06/22/2006 | US20060135545 derivatives of acronycine such as cis-2-cinnamoyloxy-1-hydroxy-6-methoxy-3,3,14-trimethyl-1,2,3,14-tetrahydro-1H-benzo[b]pyrano[3,2-h]acridin-7-one, used as antitumor agents |
| 06/22/2006 | US20060135543 N4-(1,4-Benzoxazin-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine or a salt, hydrate, solvate and/or N-oxide; inhibit the IgE and/or IgG receptor signaling cascades that lead to the release of chemical mediators; Syk kinase inhibitors |
| 06/22/2006 | CA2592288A1 Process for the preparation of galanthamine hydrobromide |
| 06/22/2006 | CA2591438A1 Novel heterocyclic compounds useful for the treatment of inflammatory and allergic disorders |
| 06/22/2006 | CA2590979A1 Novel farnesyl protein transferase inhibitors and their use to treat cancer |
| 06/22/2006 | CA2590039A1 Octahydropyrano[3,4-c]pyrrole tachykinin receptor antagonists |
| 06/22/2006 | CA2588389A1 Substituted phenols as active agents inhibiting vegf production |
| 06/22/2006 | CA2529630A1 New derivatives of benzo[b]pyrano[3,2-h] acridin-7-one cinnamates, their preparation process and the pharmaceutical compositions that contain them |
| 06/21/2006 | EP1670840A1 Process for making amide acetals |
| 06/21/2006 | EP1670804A2 Heterobicyclic compounds as pharmaceutically active agents |
| 06/21/2006 | EP1670768A1 Compounds and methods for treating dyslipidemia |
| 06/21/2006 | EP1670767A2 Resolution of a narwedine amide derivative |
| 06/21/2006 | EP1049662B1 Inhibitors of alpha4 mediated cell adhesion |
| 06/21/2006 | CN1791600A Benzothiazole derivatives as adenosine receptor ligands |
| 06/21/2006 | CN1791583A 2-substituted pyrimidines. |
| 06/21/2006 | CN1791410A Methods for treating or preventing an inflammatory or metabolic condition by inhibiting JNK |
| 06/21/2006 | CN1789246A Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases |
| 06/21/2006 | CN1260230C Production process of camptothecin |
| 06/21/2006 | CN1260229C Method for separating lycoramine from plant extract |
| 06/21/2006 | CN1260228C Method for separating galanthamine from plant extract |
| 06/20/2006 | US7064215 Nitrogen compounds such as 3-(5-morpholin-4-yl-1H-benz-imidazol-2-yl)-1H-indazole and/or isomers, used as immunology modulators, antidiabetic agents, antiogenesis inhibitors or for prophylaxis of Alzheimer's disease |
| 06/20/2006 | US7064207 Androgen receptor antagonists |
| 06/20/2006 | US7064200 Process for the synthesis of 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one compounds, and application in the synthesis of ivabradine and addition salts thereof with a pharmaceutically acceptable acid |
| 06/20/2006 | CA2235017C 4a,5a,8a,8b-tetrahydro-6h-pyrrolo[3,4':4,5]furo(3,2-b)pyridine-6,8[7h]-dione derivatives for use in controlling endoparasites and a method of producing said derivatives |
| 06/20/2006 | CA2177392C Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 06/15/2006 | WO2006062839A1 Use of dioxindoindazoles and dioxoloindazoles for treating glaucoma |
| 06/15/2006 | WO2006061392A2 Substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/15/2006 | WO2005117986A3 Antibody drug conjugates and methods |
| 06/15/2006 | WO2005058843A8 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 06/15/2006 | US20060128957 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/15/2006 | US20060128903 Process for the controlled increase in the molecular weight of polyethylenes |
| 06/15/2006 | US20060128756 Heteroaryl-substituted pyrrole derivatives, their preparation and their therapeutic uses |
| 06/15/2006 | US20060128750 Targeting chemokine receptors and interfere with the binding of the natural ligand thereto; antagonists or agonists; protecting target cells from HIV infection; treating HIV or FIV infected patients |
| 06/15/2006 | US20060128747 To treat Gram-positive bacterial infections; antibacterial and/or antifungal properties; Preferably drug-resistant strains of bacteria |
| 06/15/2006 | US20060128740 Tricyclic androgen receptor modulator compounds and methods |
| 06/15/2006 | US20060128737 Androgen receptor agonists |
| 06/15/2006 | US20060128700 e.g. 2-[1-(2-Fluorobenzyl)-1H-indazol-3-yl]-5-(3-oxa-9-azabicyclo[3.3.1]non-9-yl)-4pyrimidinylamine; soluble guanylate cyclase stimulant; neurodegenerative diseases, cognition activator; Alhzeimer's, Parkinson's disease, Pick's syndrome, multiple sclerosis, HIV dementia, schizophrenia |
| 06/15/2006 | US20060128692 Non nucleoside reverse transcriptase inhibitors |
| 06/15/2006 | US20060128685 Pyrazole derivative |
| 06/15/2006 | US20060128669 3-(4-Fluorobenzyl)-8-hydroxy-quinoline-5,7-dicarboxylic acid 7-methylester; against Human T Cell leukemia virus, Feline and Simian immunodeficiency viruses, AIDS and related clinical symptoms |
| 06/15/2006 | US20060128668 Formed by selective phosphorylation of phenpanstatin with tetrabutylammonium dihydrogen phosphate and dicyclohexylcarbodiimide in pyridine followed by cation exchange; cancer cell inhibitors |
| 06/15/2006 | CA2588760A1 Substituted tetracyclic tetrahydropyran, pyrrolidine and tetrahydrothiophene derivatives |
| 06/14/2006 | EP1669357A1 SUBSTANCE WHICH EXHIBITS ANTIVIRAL AND ANTIBACTERIAL ACTIVITY AND IS BASED ON DERIVATIVES OF 2,8-DITHIOXO-1H-PYRANO 2,3D&cedi l;6,5-D DIPYRIMIDYNE AND 10-AZA-ANALOGUE THEREOF |
| 06/14/2006 | EP1669356A1 CCR1 Antagonists for the treatment of i.a demyelinating inflammatory disease |
| 06/14/2006 | EP1669348A1 Novel antifungal agent comprising heterocyclic compound |
| 06/14/2006 | EP1668016A1 Ligands |
| 06/14/2006 | EP1668009A1 Hcv inhibitors and methods of using them |
| 06/14/2006 | EP1668004A1 Benzoxazole acetonitriles |
| 06/14/2006 | EP1667965A2 Bridged macrocyclic module compositions |
| 06/14/2006 | EP1667770A2 Novel derivatives of 4a,5,9,10,11,12-hexahydrobenzofuro [3a,3,2][ 2]- benzazepine, method for the production thereof and use thereof in the production of medicaments |
| 06/14/2006 | EP1667769A2 Use of galanthamine and the derivatives thereof in the production of medicaments |
| 06/14/2006 | EP1572696B1 Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones |
| 06/14/2006 | EP1377577B1 Pyrrole derivates for treating cytokine mediated diseases |
| 06/14/2006 | EP1214324B1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 06/14/2006 | EP1017675B1 Highly lipophilic camptothecin derivatives |
| 06/14/2006 | CN1788010A Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin |
| 06/14/2006 | CN1788000A Phthalazinone derivatives |
| 06/14/2006 | CN1787995A Alpha, omega-dicarboximide derivatives as useful uro-selective alpha1alpha adrenoceptor blockers |
| 06/14/2006 | CN1787994A 2,4,6-phenyl substituted cyclic ketoenols |
| 06/14/2006 | CN1787823A 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 06/14/2006 | CN1785261A Hotseason grow corydaline, its preparation method and its medicinal composition |
| 06/14/2006 | CN1259320C Application of alkaloid in cephalataxus fortunei esters for preventing and curing nematodiasis of plants |
| 06/13/2006 | US7060850 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof |
| 06/13/2006 | US7060844 (3Z)-3-(2,3-dihydro-1H-inden-1-ylidene)-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 06/13/2006 | US7060840 Using a chiral, non-racemic tertiary amine catalyst,e.g., one containing a 1-azabicyclo(2.2.2)octane moiety or a 1,4-diazabicyclo(2.2.2)octane moiety. |